Demo · Report
Master Snapshot
Quick-reference clinical snapshot: top clinical flags, dominant functional state, primary networks affected, and initial clinical direction.
Clinicians
Master Snapshot
Sample output from demo run — generated by EEG Paradox Decoder v1.0.4
EEG PARADOX – CLINICAL SNAPSHOT
TOP CLINICAL FLAGS (Ranked)
🔴 SEVERE F3 Low Alpha (EO) at F3 (EO) — Severe (z = -4.30) 🔴 SEVERE F3 Migraine Active Phase (EO) at F3 (EO) — Severe (z = -4.30) 🔴 SEVERE Frontal Alpha Asymmetry (EO) - Mild at F3 (EO) — Severe (z = -4.30) 🔴 SEVERE Frontal Alpha Asymmetry (EO) - Moderate at F3 (EO) — Severe (z = -4.30) 🔴 SEVERE Frontal Alpha Asymmetry (EO) - Severe at F3 (EO) — Severe (z = -4.30) 🔴 SEVERE F4 Low Alpha (EO) at F4 (EO) — Severe (z = -4.29) 🔴 SEVERE F4 Migraine Active Phase (EO) at F4 (EO) — Severe (z = -4.29)
DOMINANT FUNCTIONAL STATE
- Dominant State: Unknown / V0
- Stability: 100/100
PRIMARY NETWORKS AFFECTED
- 1Frontal Network — Executive function, attention regulation, working memory
- 2Parietal Network — Sensory integration, spatial processing, attention
- 3Occipital Network — Visual processing, alpha generation
- 4Central Network — Motor control, sensorimotor integration, attention
INITIAL CLINICAL DIRECTION
- Frontal alpha is typically lower than posterior alpha in normal wakefulness. If
- Frontal inefficiency phenotype indicates executive dysfunction. Note: Frontal al
- Under-arousal phenotype indicates low activation
Provenance & protocol graph
Each suggestion is traceable to a rule (rule_id and rule_version), with inputs (condition/phenotype, site) and thresholds used. Alternates, if-this-fails, and stabilization gates form the protocol graph; see full treatment report for CASCADE RATIONALE and PROTOCOL OPTIONS & SEQUENCING.
State integrity
Target leverage ranking
- 1O1 (score: 1.127)
- 2P8 (score: 0.886)
- 3F3 (score: 0.835)
- 4O2 (score: 0.782)
- 5P7 (score: 0.569)
Decision confidence
- Alpha Normalization (Posterior Primary / Frontal if Asymmetry): High
- Frontal Network Efficiency: Moderate
- Under-Arousal Correction: Moderate
Norm–connectivity concordance
Suggested intervention nodes
- O2 (delta): bottleneck=0.000, driver=0.367
- O1 (delta): bottleneck=0.000, driver=0.355
- P8 (delta): bottleneck=0.000, driver=0.308
- FP1 (delta): bottleneck=0.000, driver=0.192
- P7 (delta): bottleneck=0.000, driver=0.141
INTERPRETIVE NARRATIVE (Network-Level Functional Analysis)
The following sections group findings by brain network. Patterns are phenomenological observations, not diagnoses. Correlation with symptoms (anxiety, fatigue, cognitive strain) is advised.
FRONTAL NETWORK (Fp1, Fp2, F3, F4, F7, F8, Fz)
Executive function, attention regulation, working memory
- F3 Low Alpha (EO) at F3 (severe, confidence 1.00)
- F3 Migraine Active Phase (EO) at F3 (severe, confidence 1.00)
- Frontal Alpha Asymmetry (EO) - Mild at F3 (severe, confidence 1.00)
- Frontal Alpha Asymmetry (EO) - Moderate at F3 (severe, confidence 1.00)
- Frontal Alpha Asymmetry (EO) - Severe at F3 (severe, confidence 1.00)
clinical correlation and symptom history.
CENTRAL NETWORK (C3, C4, Cz)
Motor control, sensorimotor integration, attention
- C3 Left Motor Control Deficit (EO) at C3 (severe, confidence 1.00)
- C4 Right Motor Control Deficit (EO) at C4 (severe, confidence 1.00)
- C3 Left Motor Relaxation Deficit (EC) at C3 (severe, confidence 1.00)
- C4 Right Motor Relaxation Deficit (EC) at C4 (severe, confidence 1.00)
clinical correlation and symptom history.
PARIETAL NETWORK (P3, P4, Pz, P7, P8)
Sensory integration, spatial processing, attention
- P3 Left Parietal Relaxation Deficit (EO) at P3 (severe, confidence 1.00)
- P4 Right Parietal Relaxation Deficit (EO) at P4 (severe, confidence 1.00)
- P7 SMR Deficiency (EO) at P7 (severe, confidence 1.00)
- P7 Left Parietal Processing Deficit (EO) at P7 (severe, confidence 1.00)
- P7 Left Parietal Underarousal (EO) at P7 (severe, confidence 1.00)
clinical correlation and symptom history.
OCCIPITAL NETWORK (O1, O2, Oz)
Visual processing, alpha generation
- Anxiety Risk at O1 (severe, confidence 1.00)
- Occipital Alpha Deficiency at O1 (severe, confidence 1.00)
- Low Theta/Beta (O1 EO) at O1 (severe, confidence 1.00)
- Very Low Theta/Beta (O1 EC) at O1 (severe, confidence 1.00)
- Occipital Alpha Suppression (PTSD/Trauma) at O1 (severe, confidence 1.00)
clinical correlation and symptom history.
QUANTITATIVE DEVIATIONS (Evidence)
- Theta (EO): 21.23 (z=-2.80)
- Delta (EO): 45.37 (z=-2.08)
- HiBeta (EO): 7.37 (z=-6.50)
- Gamma (EO): 4.36 (z=-10.01)
- Theta/Beta (EO): 1.17 (z=-2.89)
- Theta (EC): 15.31 (z=-3.18)
- Delta (EC): 38.95 (z=-2.53)
- HiBeta (EC): 6.13 (z=-6.62)
- Gamma (EC): 4.57 (z=-9.97)
- Theta/Beta (EC): 0.97 (z=-3.25)
- Theta (EO): 19.74 (z=-3.07)
- Delta (EO): 41.71 (z=-2.03)
- HiBeta (EO): 9.46 (z=-6.83)
- Gamma (EO): 4.84 (z=-9.22)
- Theta/Beta (EO): 0.99 (z=-3.20)
- Theta (EC): 15.24 (z=-3.37)
- Delta (EC): 40.11 (z=-2.12)
- HiBeta (EC): 6.75 (z=-7.11)
- Gamma (EC): 4.90 (z=-9.21)
- Theta/Beta (EC): 0.93 (z=-3.31)
- Theta (EO): 18.80 (z=-3.41)
- Delta (EO): 37.17 (z=-2.43)
- HiBeta (EO): 6.39 (z=-6.43)
- Gamma (EO): 6.79 (z=-7.39)
- Theta/Beta (EO): 0.92 (z=-3.64)
- Theta (EC): 12.20 (z=-3.88)
- Delta (EC): 23.06 (z=-3.37)
- HiBeta (EC): 6.08 (z=-6.46)
- Gamma (EC): 6.16 (z=-7.47)
- Theta/Beta (EC): 0.75 (z=-3.89)
- Theta (EO): 19.84 (z=-2.77)
- HiBeta (EO): 5.38 (z=-7.80)
- Gamma (EO): 4.72 (z=-10.36)
- Theta/Beta (EO): 1.13 (z=-3.05)
- Theta (EC): 15.44 (z=-3.05)
- Delta (EC): 35.08 (z=-2.41)
- HiBeta (EC): 4.89 (z=-7.86)
- Gamma (EC): 5.00 (z=-10.32)
- Theta/Beta (EC): 0.93 (z=-3.39)
- Alpha (EO): 14.13 (z=-2.86)
- HiBeta (EO): 8.65 (z=-2.55)
- Gamma (EO): 11.25 (z=-2.90)
- Theta/Beta (EO): 0.91 (z=-3.52)
- Theta (EC): 12.98 (z=-2.28)
- Beta (EC): 19.78 (z=-2.01)
- HiBeta (EC): 6.26 (z=-2.70)
- Gamma (EC): 8.60 (z=-3.09)
- Theta/Beta (EC): 0.81 (z=-3.68)
- Theta (EO): 20.75 (z=-3.15)
- HiBeta (EO): 8.56 (z=-6.92)
- Gamma (EO): 4.74 (z=-10.87)
- Theta/Beta (EO): 1.09 (z=-3.18)
- Theta (EC): 15.84 (z=-3.49)
- Delta (EC): 39.59 (z=-2.11)
- HiBeta (EC): 6.06 (z=-7.18)
- Gamma (EC): 4.50 (z=-10.91)
- Theta/Beta (EC): 1.00 (z=-3.33)
- Theta (EO): 20.41 (z=-3.31)
- HiBeta (EO): 6.39 (z=-7.73)
- Gamma (EO): 5.17 (z=-9.12)
- Theta/Beta (EO): 1.15 (z=-3.09)
- Theta (EC): 16.54 (z=-3.59)
- Delta (EC): 40.40 (z=-2.01)
- HiBeta (EC): 6.44 (z=-7.72)
- Gamma (EC): 5.54 (z=-9.06)
- Theta/Beta (EC): 0.98 (z=-3.39)
- Alpha (EO): 9.54 (z=-3.23)
- Theta (EO): 14.21 (z=-2.19)
- Beta (EO): 12.24 (z=-2.61)
- HiBeta (EO): 5.72 (z=-2.74)
- Gamma (EO): 4.31 (z=-3.41)
- Theta/Beta (EO): 1.08 (z=-3.17)
- Alpha (EC): 15.87 (z=-2.72)
- Theta (EC): 13.53 (z=-2.24)
- Beta (EC): 10.71 (z=-2.74)
- HiBeta (EC): 4.36 (z=-2.83)
- Gamma (EC): 4.78 (z=-3.38)
- Theta/Beta (EC): 1.12 (z=-3.09)
- Alpha (EO): 9.29 (z=-3.25)
- Theta (EO): 12.52 (z=-2.32)
- Beta (EO): 12.74 (z=-2.58)
- HiBeta (EO): 6.08 (z=-2.72)
- Gamma (EO): 4.23 (z=-3.42)
- Theta/Beta (EO): 0.99 (z=-3.20)
- Alpha (EC): 15.34 (z=-2.76)
- Theta (EC): 13.83 (z=-2.21)
- Beta (EC): 11.53 (z=-2.67)
- HiBeta (EC): 4.50 (z=-2.82)
- Gamma (EC): 5.01 (z=-3.36)
- Theta/Beta (EC): 1.10 (z=-3.01)
- Theta (EO): 20.55 (z=-3.02)
- Delta (EO): 42.78 (z=-2.19)
- HiBeta (EO): 6.68 (z=-7.37)
- Gamma (EO): 4.90 (z=-9.41)
- Theta/Beta (EO): 1.09 (z=-3.17)
- Theta (EC): 13.48 (z=-3.46)
- Delta (EC): 33.07 (z=-2.81)
- HiBeta (EC): 4.98 (z=-7.55)
- Gamma (EC): 5.36 (z=-9.34)
- Theta/Beta (EC): 0.88 (z=-3.52)
- Alpha (EO): 13.67 (z=-2.90)
- Beta (EO): 17.04 (z=-2.23)
- HiBeta (EO): 6.73 (z=-2.67)
- Gamma (EO): 7.98 (z=-3.14)
- Theta/Beta (EO): 1.06 (z=-3.29)
- Alpha (EC): 20.49 (z=-2.35)
- Theta (EC): 14.73 (z=-2.15)
- Beta (EC): 15.53 (z=-2.35)
- HiBeta (EC): 5.96 (z=-2.72)
- Gamma (EC): 8.77 (z=-3.08)
- Theta/Beta (EC): 0.97 (z=-3.44)
- Alpha (EO): 12.84 (z=-2.96)
- Beta (EO): 16.24 (z=-2.29)
- HiBeta (EO): 7.40 (z=-2.63)
- Gamma (EO): 6.62 (z=-3.24)
- Theta/Beta (EO): 1.06 (z=-3.27)
- Alpha (EC): 23.31 (z=-2.12)
- Theta (EC): 12.16 (z=-2.34)
- Beta (EC): 15.25 (z=-2.37)
- HiBeta (EC): 5.56 (z=-2.75)
- Gamma (EC): 8.06 (z=-3.14)
- Theta/Beta (EC): 0.89 (z=-3.55)
- Theta (EO): 19.27 (z=-3.66)
- HiBeta (EO): 8.70 (z=-6.94)
- Gamma (EO): 4.92 (z=-9.27)
- Theta/Beta (EO): 1.06 (z=-3.20)
- Theta (EC): 15.56 (z=-3.93)
- HiBeta (EC): 6.26 (z=-7.19)
- Gamma (EC): 4.76 (z=-9.30)
- Theta/Beta (EC): 1.01 (z=-3.29)
- Theta (EO): 17.07 (z=-3.31)
- Delta (EO): 38.35 (z=-2.35)
- HiBeta (EO): 6.31 (z=-7.58)
- Gamma (EO): 6.06 (z=-7.68)
- Theta/Beta (EO): 0.91 (z=-3.45)
- Theta (EC): 11.47 (z=-3.70)
- Delta (EC): 25.69 (z=-3.10)
- HiBeta (EC): 5.16 (z=-7.70)
- Gamma (EC): 5.29 (z=-7.78)
- Theta/Beta (EC): 0.78 (z=-3.67)
- Alpha (EO): 11.92 (z=-3.04)
- Theta (EO): 15.89 (z=-2.06)
- HiBeta (EO): 9.72 (z=-2.48)
- Gamma (EO): 9.16 (z=-3.05)
- Theta/Beta (EO): 0.87 (z=-3.41)
- Alpha (EC): 17.21 (z=-2.61)
- Theta (EC): 13.16 (z=-2.27)
- Beta (EC): 15.97 (z=-2.31)
- HiBeta (EC): 6.61 (z=-2.68)
- Gamma (EC): 9.53 (z=-3.03)
- Theta/Beta (EC): 0.91 (z=-3.35)
- Alpha (EO): 14.92 (z=-2.80)
- Beta (EO): 19.10 (z=-2.06)
- HiBeta (EO): 6.51 (z=-2.69)
- Gamma (EO): 6.62 (z=-3.24)
- Theta/Beta (EO): 1.04 (z=-3.25)
- Theta (EC): 11.27 (z=-2.41)
- Delta (EC): 29.12 (z=-2.10)
- Beta (EC): 17.20 (z=-2.22)
- HiBeta (EC): 5.06 (z=-2.78)
- Gamma (EC): 6.38 (z=-3.26)
- Theta/Beta (EC): 0.81 (z=-3.64)
- Theta (EO): 20.04 (z=-3.00)
- Delta (EO): 41.90 (z=-2.17)
- HiBeta (EO): 6.18 (z=-6.83)
- Gamma (EO): 5.66 (z=-8.42)
- Theta/Beta (EO): 1.05 (z=-3.28)
- Theta (EC): 16.14 (z=-3.26)
- Delta (EC): 34.18 (z=-2.66)
- HiBeta (EC): 5.22 (z=-6.92)
- Gamma (EC): 5.75 (z=-8.41)
- Theta/Beta (EC): 0.91 (z=-3.52)
- Theta (EO): 21.20 (z=-3.12)
- HiBeta (EO): 9.21 (z=-6.12)
- Gamma (EO): 4.80 (z=-9.11)
- Theta/Beta (EO): 1.10 (z=-3.03)
- Theta (EC): 14.47 (z=-3.58)
- Delta (EC): 36.12 (z=-2.34)
- HiBeta (EC): 6.40 (z=-6.37)
- Gamma (EC): 5.49 (z=-9.01)
- Theta/Beta (EC): 0.92 (z=-3.34)
- Alpha (EO): 10.84 (z=-3.12)
- Beta (EO): 15.25 (z=-2.37)
- HiBeta (EO): 6.84 (z=-2.67)
- Gamma (EO): 5.80 (z=-3.30)
- Theta/Beta (EO): 1.08 (z=-3.17)
- Alpha (EC): 18.14 (z=-2.54)
- Theta (EC): 13.86 (z=-2.21)
- Beta (EC): 12.43 (z=-2.60)
- HiBeta (EC): 4.72 (z=-2.80)
- Gamma (EC): 6.88 (z=-3.22)
- Theta/Beta (EC): 1.06 (z=-3.21)
RECOGNIZED EEG FUNCTIONAL PATTERNS
- Frontal Alpha Suppression Pattern (confidence: 1.00)
- Occipital Alpha Suppression Pattern (confidence: 1.00)
- Occipital Theta Suppression Pattern (confidence: 1.00)
- Frontal SMR Suppression Pattern (confidence: 1.00)
- Temporal Beta Excess Pattern (confidence: 0.45)
IF YOU DO NOTHING ELSE, DO THIS
- 1Alpha Normalization (Posterior Primary / Frontal if Asymmetry) Protocol: Consider posterior alpha enhancement (O1, O2, Pz) with natural spread OR frontal alpha normalization if asymmetry present (8-12 Hz) Rationale: Frontal alpha is typically lower than posterior alpha in normal wakefulness. If frontal alpha asymmetry (F3 < F4) is present, normalize asymmetry rather than general uptraining. Posterior alpha enhancement is the more standard approach and may allow natural spread to frontal regions. Framework: Swingle Timeline: 8–12 sessions
- 1Frontal Network Efficiency Protocol: Posterior alpha enhancement (O1, O2, Pz) with spread OR frontal alpha normalization if asymmetry present (8-12 Hz), regulation training Rationale: Frontal inefficiency phenotype indicates executive dysfunction. Note: Frontal alpha is typically lower than posterior alpha in normal wakefulness. Posterior alpha enhancement is the more standard approach. If frontal alpha asymmetry (F3 < F4) is present, normalize asymmetry rather than general uptraining. Framework: Phenotypes Timeline: 8–12 sessions
- 1Under-Arousal Correction Protocol: Theta reduction, Beta enhancement, activation protocols Rationale: Under-arousal phenotype indicates low activation Framework: Phenotypes Timeline: 8–12 sessions
APPENDIX: How the Analysis Was Performed
Automated quantitative analysis using normative frameworks (e.g., swingle, cuban, cuban2ndwave). Protocol flow, systems analysis, and full treatment cascade are available in protocol_flow_report.txt, systems_report.txt, and treatment_report.txt respectively.
EEG Paradox Clinical Pattern Detection System
More in Systems & Vigilance
All outputs shown are from sample data for illustration only. EEG Paradox Solutions provides non-clinical informational services. Licensed clinicians interpret the results.